nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—CYP1A2—Methimazole—Graves' disease	0.304	0.426	CbGbCtD
Asenapine—CYP2D6—Methimazole—Graves' disease	0.251	0.351	CbGbCtD
Asenapine—CYP3A4—Methimazole—Graves' disease	0.159	0.223	CbGbCtD
Asenapine—Traumatic liver injury—Propylthiouracil—Graves' disease	0.0327	0.217	CcSEcCtD
Asenapine—Liver injury—Propylthiouracil—Graves' disease	0.0145	0.0962	CcSEcCtD
Asenapine—Agranulocytosis—Methimazole—Graves' disease	0.00747	0.0497	CcSEcCtD
Asenapine—Agranulocytosis—Propylthiouracil—Graves' disease	0.00635	0.0422	CcSEcCtD
Asenapine—Leukopenia—Methimazole—Graves' disease	0.0056	0.0372	CcSEcCtD
Asenapine—Arthralgia—Methimazole—Graves' disease	0.00532	0.0354	CcSEcCtD
Asenapine—Dysgeusia—Propylthiouracil—Graves' disease	0.00521	0.0346	CcSEcCtD
Asenapine—Thrombocytopenia—Methimazole—Graves' disease	0.005	0.0332	CcSEcCtD
Asenapine—Leukopenia—Propylthiouracil—Graves' disease	0.00476	0.0317	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00465	0.0309	CcSEcCtD
Asenapine—Somnolence—Methimazole—Graves' disease	0.00454	0.0302	CcSEcCtD
Asenapine—Arthralgia—Propylthiouracil—Graves' disease	0.00453	0.0301	CcSEcCtD
Asenapine—Dyspepsia—Methimazole—Graves' disease	0.00449	0.0299	CcSEcCtD
Asenapine—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00425	0.0283	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00395	0.0263	CcSEcCtD
Asenapine—Somnolence—Propylthiouracil—Graves' disease	0.00386	0.0257	CcSEcCtD
Asenapine—Dyspepsia—Propylthiouracil—Graves' disease	0.00382	0.0254	CcSEcCtD
Asenapine—Vomiting—Methimazole—Graves' disease	0.00325	0.0216	CcSEcCtD
Asenapine—Rash—Methimazole—Graves' disease	0.00322	0.0214	CcSEcCtD
Asenapine—Dermatitis—Methimazole—Graves' disease	0.00322	0.0214	CcSEcCtD
Asenapine—Headache—Methimazole—Graves' disease	0.0032	0.0213	CcSEcCtD
Asenapine—Nausea—Methimazole—Graves' disease	0.00303	0.0202	CcSEcCtD
Asenapine—Vomiting—Propylthiouracil—Graves' disease	0.00276	0.0184	CcSEcCtD
Asenapine—Rash—Propylthiouracil—Graves' disease	0.00274	0.0182	CcSEcCtD
Asenapine—Dermatitis—Propylthiouracil—Graves' disease	0.00273	0.0182	CcSEcCtD
Asenapine—Headache—Propylthiouracil—Graves' disease	0.00272	0.0181	CcSEcCtD
Asenapine—Nausea—Propylthiouracil—Graves' disease	0.00258	0.0171	CcSEcCtD
Asenapine—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000245	0.00182	CbGpPWpGaD
Asenapine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000245	0.00182	CbGpPWpGaD
Asenapine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000243	0.0018	CbGpPWpGaD
Asenapine—DRD2—GPCR ligand binding—TSHR—Graves' disease	0.000243	0.0018	CbGpPWpGaD
Asenapine—HTR6—GPCR ligand binding—CXCL10—Graves' disease	0.000241	0.00179	CbGpPWpGaD
Asenapine—HTR7—GPCR ligand binding—CXCL10—Graves' disease	0.000241	0.00179	CbGpPWpGaD
Asenapine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00024	0.00178	CbGpPWpGaD
Asenapine—HTR1D—GPCR ligand binding—CXCL10—Graves' disease	0.000239	0.00177	CbGpPWpGaD
Asenapine—HTR2A—GPCR ligand binding—TSHR—Graves' disease	0.000239	0.00177	CbGpPWpGaD
Asenapine—HRH1—GPCR ligand binding—TSHR—Graves' disease	0.000238	0.00177	CbGpPWpGaD
Asenapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000238	0.00176	CbGpPWpGaD
Asenapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000234	0.00174	CbGpPWpGaD
Asenapine—HTR1B—GPCR ligand binding—CXCL10—Graves' disease	0.000234	0.00174	CbGpPWpGaD
Asenapine—ADRA1A—GPCR ligand binding—TSHR—Graves' disease	0.000234	0.00173	CbGpPWpGaD
Asenapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000233	0.00173	CbGpPWpGaD
Asenapine—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000232	0.00172	CbGpPWpGaD
Asenapine—DRD4—GPCR ligand binding—CXCL10—Graves' disease	0.000231	0.00171	CbGpPWpGaD
Asenapine—ADRA2C—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000229	0.0017	CbGpPWpGaD
Asenapine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000227	0.00168	CbGpPWpGaD
Asenapine—DRD2—Circadian rythm related genes—FAS—Graves' disease	0.000226	0.00167	CbGpPWpGaD
Asenapine—HTR2B—GPCR ligand binding—CXCL10—Graves' disease	0.00022	0.00163	CbGpPWpGaD
Asenapine—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	0.000217	0.00161	CbGpPWpGaD
Asenapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000212	0.00157	CbGpPWpGaD
Asenapine—HTR6—GPCR downstream signaling—TSHR—Graves' disease	0.000211	0.00156	CbGpPWpGaD
Asenapine—HTR7—GPCR downstream signaling—TSHR—Graves' disease	0.000211	0.00156	CbGpPWpGaD
Asenapine—HTR1D—GPCR downstream signaling—TSHR—Graves' disease	0.000209	0.00155	CbGpPWpGaD
Asenapine—DRD1—GPCR ligand binding—CXCL10—Graves' disease	0.000208	0.00154	CbGpPWpGaD
Asenapine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000206	0.00153	CbGpPWpGaD
Asenapine—HTR1B—GPCR downstream signaling—TSHR—Graves' disease	0.000205	0.00152	CbGpPWpGaD
Asenapine—DRD3—GPCR ligand binding—CXCL10—Graves' disease	0.000205	0.00152	CbGpPWpGaD
Asenapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000203	0.0015	CbGpPWpGaD
Asenapine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000202	0.0015	CbGpPWpGaD
Asenapine—DRD4—GPCR downstream signaling—TSHR—Graves' disease	0.000202	0.0015	CbGpPWpGaD
Asenapine—HTR1E—GPCR downstream signaling—CXCL10—Graves' disease	0.0002	0.00148	CbGpPWpGaD
Asenapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000198	0.00147	CbGpPWpGaD
Asenapine—HTR5A—Signaling Pathways—CXCL10—Graves' disease	0.000198	0.00147	CbGpPWpGaD
Asenapine—HTR2B—GPCR downstream signaling—TSHR—Graves' disease	0.000193	0.00143	CbGpPWpGaD
Asenapine—SLC6A4—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000192	0.00142	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—TSHR—Graves' disease	0.000192	0.00142	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—TSHR—Graves' disease	0.000191	0.00142	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—TSHR—Graves' disease	0.00019	0.00141	CbGpPWpGaD
Asenapine—ADRB1—GPCR ligand binding—CXCL10—Graves' disease	0.000187	0.00138	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—TSHR—Graves' disease	0.000186	0.00138	CbGpPWpGaD
Asenapine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000186	0.00138	CbGpPWpGaD
Asenapine—ADRA2B—GPCR ligand binding—CXCL10—Graves' disease	0.000185	0.00137	CbGpPWpGaD
Asenapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000184	0.00137	CbGpPWpGaD
Asenapine—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000184	0.00136	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—TSHR—Graves' disease	0.000183	0.00136	CbGpPWpGaD
Asenapine—ADRB2—GPCR ligand binding—CXCL10—Graves' disease	0.000183	0.00135	CbGpPWpGaD
Asenapine—DRD1—GPCR downstream signaling—TSHR—Graves' disease	0.000182	0.00135	CbGpPWpGaD
Asenapine—HTR1E—Signaling by GPCR—CXCL10—Graves' disease	0.000181	0.00134	CbGpPWpGaD
Asenapine—DRD3—GPCR downstream signaling—TSHR—Graves' disease	0.000179	0.00133	CbGpPWpGaD
Asenapine—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	0.000179	0.00132	CbGpPWpGaD
Asenapine—HRH2—GPCR downstream signaling—CXCL10—Graves' disease	0.000178	0.00132	CbGpPWpGaD
Asenapine—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	0.000178	0.00132	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—TSHR—Graves' disease	0.000175	0.0013	CbGpPWpGaD
Asenapine—ADRA2C—GPCR ligand binding—CXCL10—Graves' disease	0.000173	0.00128	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—TSHR—Graves' disease	0.000166	0.00123	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—TSHR—Graves' disease	0.000165	0.00122	CbGpPWpGaD
Asenapine—ADRB1—GPCR downstream signaling—TSHR—Graves' disease	0.000163	0.00121	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—TSHR—Graves' disease	0.000163	0.00121	CbGpPWpGaD
Asenapine—ADRA2B—GPCR downstream signaling—TSHR—Graves' disease	0.000162	0.0012	CbGpPWpGaD
Asenapine—HRH2—Signaling by GPCR—CXCL10—Graves' disease	0.000161	0.0012	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—TSHR—Graves' disease	0.00016	0.00118	CbGpPWpGaD
Asenapine—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000159	0.00118	CbGpPWpGaD
Asenapine—DRD2—GPCR ligand binding—CXCL10—Graves' disease	0.000157	0.00116	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	0.000156	0.00116	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000155	0.00115	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	0.000155	0.00115	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—GC—Graves' disease	0.000154	0.00114	CbGpPWpGaD
Asenapine—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	0.000154	0.00114	CbGpPWpGaD
Asenapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000154	0.00114	CbGpPWpGaD
Asenapine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000154	0.00114	CbGpPWpGaD
Asenapine—HRH1—GPCR ligand binding—CXCL10—Graves' disease	0.000154	0.00114	CbGpPWpGaD
Asenapine—HTR1E—GPCR downstream signaling—IL2RA—Graves' disease	0.000153	0.00113	CbGpPWpGaD
Asenapine—HTR5A—Signaling Pathways—IL2RA—Graves' disease	0.000152	0.00112	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—TSHR—Graves' disease	0.000151	0.00112	CbGpPWpGaD
Asenapine—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	0.000151	0.00112	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—TSHR—Graves' disease	0.000148	0.0011	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TSHR—Graves' disease	0.000148	0.00109	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—TSHR—Graves' disease	0.000147	0.00109	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—TSHR—Graves' disease	0.000145	0.00108	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—TSHR—Graves' disease	0.000142	0.00105	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—TSHR—Graves' disease	0.000141	0.00105	CbGpPWpGaD
Asenapine—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	0.00014	0.00104	CbGpPWpGaD
Asenapine—HTR1E—Signaling by GPCR—IL2RA—Graves' disease	0.000139	0.00103	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—TSHR—Graves' disease	0.000137	0.00102	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—TSHR—Graves' disease	0.000137	0.00102	CbGpPWpGaD
Asenapine—HTR6—GPCR downstream signaling—CXCL10—Graves' disease	0.000136	0.00101	CbGpPWpGaD
Asenapine—HTR7—GPCR downstream signaling—CXCL10—Graves' disease	0.000136	0.00101	CbGpPWpGaD
Asenapine—HRH2—GPCR downstream signaling—IL2RA—Graves' disease	0.000136	0.00101	CbGpPWpGaD
Asenapine—HTR1D—GPCR downstream signaling—CXCL10—Graves' disease	0.000135	0.001	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	0.000135	0.001	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—TSHR—Graves' disease	0.000135	0.000998	CbGpPWpGaD
Asenapine—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000134	0.00099	CbGpPWpGaD
Asenapine—HTR1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000132	0.000982	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	0.000132	0.000979	CbGpPWpGaD
Asenapine—DRD4—GPCR downstream signaling—CXCL10—Graves' disease	0.00013	0.000966	CbGpPWpGaD
Asenapine—ADRA2B—Hemostasis—IL2RA—Graves' disease	0.000126	0.000937	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—GC—Graves' disease	0.000125	0.00093	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—TSHR—Graves' disease	0.000125	0.000923	CbGpPWpGaD
Asenapine—HTR2B—GPCR downstream signaling—CXCL10—Graves' disease	0.000124	0.000922	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—CXCL10—Graves' disease	0.000124	0.000918	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—CXCL10—Graves' disease	0.000124	0.000917	CbGpPWpGaD
Asenapine—HRH2—Signaling by GPCR—IL2RA—Graves' disease	0.000123	0.000915	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—CXCL10—Graves' disease	0.000123	0.000911	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	0.000123	0.00091	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—TSHR—Graves' disease	0.000123	0.000908	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—TSHR—Graves' disease	0.000122	0.000906	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—CXCL10—Graves' disease	0.00012	0.000892	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	0.00012	0.000889	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—CXCL10—Graves' disease	0.000118	0.000878	CbGpPWpGaD
Asenapine—ADRA2C—Hemostasis—IL2RA—Graves' disease	0.000118	0.000875	CbGpPWpGaD
Asenapine—DRD1—GPCR downstream signaling—CXCL10—Graves' disease	0.000117	0.00087	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—B3GNT2—Graves' disease	0.000117	0.000867	CbGpPWpGaD
Asenapine—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	0.000116	0.000858	CbGpPWpGaD
Asenapine—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000115	0.000856	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TSHR—Graves' disease	0.000113	0.000839	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TSHR—Graves' disease	0.000113	0.000838	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—CXCL10—Graves' disease	0.000113	0.000838	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TSHR—Graves' disease	0.000112	0.000833	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	0.000111	0.000826	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TSHR—Graves' disease	0.00011	0.000815	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TSHR—Graves' disease	0.000108	0.000802	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—CXCL10—Graves' disease	0.000107	0.000794	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—CXCL10—Graves' disease	0.000107	0.00079	CbGpPWpGaD
Asenapine—ADRB1—GPCR downstream signaling—CXCL10—Graves' disease	0.000106	0.000782	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—CXCL10—Graves' disease	0.000105	0.000779	CbGpPWpGaD
Asenapine—ADRA2B—GPCR downstream signaling—CXCL10—Graves' disease	0.000105	0.000775	CbGpPWpGaD
Asenapine—HTR6—GPCR downstream signaling—IL2RA—Graves' disease	0.000104	0.000772	CbGpPWpGaD
Asenapine—HTR7—GPCR downstream signaling—IL2RA—Graves' disease	0.000104	0.000772	CbGpPWpGaD
Asenapine—HTR1D—GPCR downstream signaling—IL2RA—Graves' disease	0.000103	0.000767	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TSHR—Graves' disease	0.000103	0.000766	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—CXCL10—Graves' disease	0.000103	0.000765	CbGpPWpGaD
Asenapine—HTR1B—GPCR downstream signaling—IL2RA—Graves' disease	0.000101	0.000751	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	0.000101	0.000748	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	0.0001	0.000744	CbGpPWpGaD
Asenapine—DRD4—GPCR downstream signaling—IL2RA—Graves' disease	9.96e-05	0.000739	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—CXCL10—Graves' disease	9.76e-05	0.000724	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TSHR—Graves' disease	9.74e-05	0.000722	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TSHR—Graves' disease	9.61e-05	0.000713	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—IL2RA—Graves' disease	9.59e-05	0.000711	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—CXCL10—Graves' disease	9.58e-05	0.00071	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—CXCL10—Graves' disease	9.54e-05	0.000707	CbGpPWpGaD
Asenapine—HTR2B—GPCR downstream signaling—IL2RA—Graves' disease	9.51e-05	0.000705	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—B3GNT2—Graves' disease	9.5e-05	0.000704	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—CXCL10—Graves' disease	9.49e-05	0.000704	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL2RA—Graves' disease	9.46e-05	0.000701	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL2RA—Graves' disease	9.45e-05	0.000701	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL2RA—Graves' disease	9.39e-05	0.000696	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—CXCL10—Graves' disease	9.37e-05	0.000695	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL2RA—Graves' disease	9.19e-05	0.000682	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	9.16e-05	0.000679	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	9.12e-05	0.000676	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL2RA—Graves' disease	9.05e-05	0.000671	CbGpPWpGaD
Asenapine—DRD1—GPCR downstream signaling—IL2RA—Graves' disease	8.97e-05	0.000665	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—CXCL10—Graves' disease	8.87e-05	0.000657	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	8.86e-05	0.000657	CbGpPWpGaD
Asenapine—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	8.85e-05	0.000656	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TSHR—Graves' disease	8.76e-05	0.000649	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	8.72e-05	0.000646	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—CXCL10—Graves' disease	8.7e-05	0.000645	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TSHR—Graves' disease	8.68e-05	0.000643	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL2RA—Graves' disease	8.64e-05	0.00064	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TSHR—Graves' disease	8.57e-05	0.000635	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	8.54e-05	0.000633	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TSHR—Graves' disease	8.38e-05	0.000621	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TSHR—Graves' disease	8.33e-05	0.000618	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL2RA—Graves' disease	8.18e-05	0.000607	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GC—Graves' disease	8.17e-05	0.000606	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL2RA—Graves' disease	8.15e-05	0.000604	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TSHR—Graves' disease	8.11e-05	0.000601	CbGpPWpGaD
Asenapine—ADRB1—GPCR downstream signaling—IL2RA—Graves' disease	8.06e-05	0.000598	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—CXCL10—Graves' disease	8.05e-05	0.000596	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL2RA—Graves' disease	8.04e-05	0.000596	CbGpPWpGaD
Asenapine—ADRA2B—GPCR downstream signaling—IL2RA—Graves' disease	7.99e-05	0.000592	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	7.93e-05	0.000588	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	7.92e-05	0.000587	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—CXCL10—Graves' disease	7.9e-05	0.000586	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—IL2RA—Graves' disease	7.89e-05	0.000585	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	7.75e-05	0.000575	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	7.71e-05	0.000572	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	7.67e-05	0.000569	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—IL2RA—Graves' disease	7.46e-05	0.000553	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TSHR—Graves' disease	7.36e-05	0.000545	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL2RA—Graves' disease	7.32e-05	0.000543	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CXCL10—Graves' disease	7.31e-05	0.000542	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CXCL10—Graves' disease	7.31e-05	0.000542	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL2RA—Graves' disease	7.29e-05	0.00054	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CXCL10—Graves' disease	7.26e-05	0.000538	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL2RA—Graves' disease	7.26e-05	0.000538	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TSHR—Graves' disease	7.24e-05	0.000536	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TSHR—Graves' disease	7.22e-05	0.000535	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	7.2e-05	0.000534	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL2RA—Graves' disease	7.16e-05	0.000531	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CXCL10—Graves' disease	7.11e-05	0.000527	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TSHR—Graves' disease	7.09e-05	0.000525	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	7e-05	0.000519	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CXCL10—Graves' disease	6.99e-05	0.000518	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	6.97e-05	0.000517	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GC—Graves' disease	6.92e-05	0.000513	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL2RA—Graves' disease	6.78e-05	0.000502	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	6.77e-05	0.000502	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CXCL10—Graves' disease	6.68e-05	0.000495	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	6.66e-05	0.000494	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—IL2RA—Graves' disease	6.65e-05	0.000493	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TSHR—Graves' disease	6.58e-05	0.000488	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	6.52e-05	0.000484	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CXCL10—Graves' disease	6.3e-05	0.000467	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CXCL10—Graves' disease	6.21e-05	0.00046	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—B3GNT2—Graves' disease	6.19e-05	0.000459	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL2RA—Graves' disease	6.15e-05	0.000456	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	6.06e-05	0.000449	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	6.05e-05	0.000449	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL2RA—Graves' disease	6.04e-05	0.000448	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	5.92e-05	0.000439	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CXCL10—Graves' disease	5.66e-05	0.00042	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CXCL10—Graves' disease	5.61e-05	0.000416	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL2RA—Graves' disease	5.59e-05	0.000414	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL2RA—Graves' disease	5.58e-05	0.000414	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL2RA—Graves' disease	5.55e-05	0.000411	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CXCL10—Graves' disease	5.54e-05	0.00041	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	5.5e-05	0.000408	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL2RA—Graves' disease	5.43e-05	0.000403	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CXCL10—Graves' disease	5.41e-05	0.000401	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CXCL10—Graves' disease	5.39e-05	0.000399	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL2RA—Graves' disease	5.34e-05	0.000396	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GC—Graves' disease	5.34e-05	0.000396	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—B3GNT2—Graves' disease	5.25e-05	0.000389	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CXCL10—Graves' disease	5.24e-05	0.000388	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL2RA—Graves' disease	5.1e-05	0.000378	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL2RA—Graves' disease	4.81e-05	0.000357	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CXCL10—Graves' disease	4.75e-05	0.000352	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL2RA—Graves' disease	4.75e-05	0.000352	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CXCL10—Graves' disease	4.68e-05	0.000347	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CXCL10—Graves' disease	4.67e-05	0.000346	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	4.58e-05	0.000339	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL2RA—Graves' disease	4.33e-05	0.000321	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL2RA—Graves' disease	4.29e-05	0.000318	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	4.25e-05	0.000315	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL2RA—Graves' disease	4.23e-05	0.000314	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL2RA—Graves' disease	4.14e-05	0.000307	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL2RA—Graves' disease	4.12e-05	0.000305	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—B3GNT2—Graves' disease	4.05e-05	0.0003	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL2RA—Graves' disease	4e-05	0.000297	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL2RA—Graves' disease	3.63e-05	0.000269	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL2RA—Graves' disease	3.57e-05	0.000265	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL2RA—Graves' disease	3.57e-05	0.000264	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	3.5e-05	0.000259	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	3.25e-05	0.000241	CbGpPWpGaD
